» Articles » PMID: 29348765

Preventive Effect and Safety of a Follicle Stimulating Hormone Inhibitory Formulation Containing a Mixture of and for Precocious Puberty: A Preliminary Experimental Study Using Female Rats

Overview
Date 2018 Jan 20
PMID 29348765
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Precocious puberty is a common endocrine disease in children. Inappropriate activation of hypothalamic-pituitary-gonadal axis leads to the development of secondary sexual characteristics at an earlier age than normal children and causes short stature in adulthood.

Objectives: The aim of this study is to evaluate the preventive effects of a herbal formulation containing a mixture of and (hEIF extract) on precocious puberty.

Methods: The preventive effect of hEIF extract on precocious puberty in rats was evaluated by measuring blood component after 3 weeks of treatment via oral administration. Network pharmacological analyses were performed to predict the bioactive components of hEIF extract.

Results: studies showed that hEIF extract significantly reduced follicle stimulating hormone (FSH) levels. After treatment with 200 mg/kg of hEIF extract, the FSH level was 5.33 ± 1.10 ng/mL, whereas the FSH level in the vehicle group was 46.73 ± 0.80 ng/mL. Moreover, the use of hEIF extract did not stimulate body growth and bone accretion in rats. The network pharmacological analysis led to the identification of multiple targets of hEIF extract related to lipolysis and the female sex hormone-related pathways.

Conclusion: hEIF extract can be used as an FSH inhibitor for the treatment of precocious puberty.

Citing Articles

Perceptions and Treatment of Precocious Puberty: A Questionnaire Survey among Caregivers in South Korea.

Shim S, Song J, Lee H Evid Based Complement Alternat Med. 2022; 2022:9413188.

PMID: 35911167 PMC: 9334087. DOI: 10.1155/2022/9413188.


Determination of Differentiating Markers in Coicis Semen From Multi-Sources Based on Structural Similarity Classification Coupled With UPCC-Xevo G2-XS QTOF.

Zhu R, Xu X, Shan Q, Wang K, Cao G, Wu X Front Pharmacol. 2020; 11:549181.

PMID: 33178013 PMC: 7596418. DOI: 10.3389/fphar.2020.549181.


YYFZBJS ameliorates colorectal cancer progression in Apc mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.

Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L Cell Commun Signal. 2020; 18(1):113.

PMID: 32677955 PMC: 7367414. DOI: 10.1186/s12964-020-00596-9.


Herbal medicine for idiopathic central precocious puberty: A protocol for a systematic review of controlled trials.

Lee H, Lee Y, Choi J, Lee J Medicine (Baltimore). 2018; 97(13):e0267.

PMID: 29595688 PMC: 5895428. DOI: 10.1097/MD.0000000000010267.

References
1.
Nguyen D, Li Calzi S, Shaw L, Kielczewski J, Korah H, Grant M . An ocular view of the IGF-IGFBP system. Growth Horm IGF Res. 2013; 23(3):45-52. PMC: 3833084. DOI: 10.1016/j.ghir.2013.03.001. View

2.
Biro F, Khoury P, Morrison J . Influence of obesity on timing of puberty. Int J Androl. 2005; 29(1):272-7. DOI: 10.1111/j.1365-2605.2005.00602.x. View

3.
Thompson I, Kaiser U . GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression. Mol Cell Endocrinol. 2013; 385(1-2):28-35. PMC: 3947649. DOI: 10.1016/j.mce.2013.09.012. View

4.
Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M . KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2011; 40(Database issue):D109-14. PMC: 3245020. DOI: 10.1093/nar/gkr988. View

5.
Jang S, Kim Y, Lee W, Kwak K, Baek S, Kwak G . Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma Plus LPS. Arch Pharm Res. 2005; 28(2):203-8. DOI: 10.1007/BF02977716. View